Stanley Laman Group, Ltd. Astrazeneca PLC Transaction History
Stanley Laman Group, Ltd.
- $652 Million
- Q4 2024
A detailed history of Stanley Laman Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 49,235 shares of AZN stock, worth $3.62 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
49,235
Previous 64,491
23.66%
Holding current value
$3.62 Million
Previous $5.03 Million
35.82%
% of portfolio
0.49%
Previous 0.78%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
477MCall Options Held
5.39MPut Options Held
3.29M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...